Symbol
| ID1
| contributors: mct/pgu - updated : 15-12-2015
|
HGNC name
| inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
HGNC id
| 5360
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --low
|  
|
in gastric cancer | tumoral
|  
|  
| --over
|  
|
in prostate cancer tissues | tumoral
|  
|  
|  
|  
|
expression in androgen-dependent prostate cancer is negatively regulated by androgen through androgen-receptor | tumoral
|  
|  
|  
|  
|
expression of mRNA in bone marrow and peripheral blood was significantly associated with lymph node metastasis and peritoneal dissemination in gastric carcinoma patients | |
Variant & Polymorphism
|
| |
Candidate gene
| plays an important role in polycythemia vera |
Marker
Therapy target
| |
|
System | Type | Disorder | Pubmed |
cancer | urinary | | |
upregulation of ID1 in bladder cancer cells lead to increased cell viability in response to epirubicin and downregulation of Id1 increases cellular sensitivity to epirubicin by increased anticancer drug-induced apoptosis | cancer | reproductive | breast | |
peptide aptamer, Id1/3-PA7, specifically interacting with ID1 and ID3, could represent a nontoxic exogenous agent that can significantly provoke antiproliferative and apoptotic effects in breast cancer cells, which are associated with deregulated expressi |
| |
| combined Id1 and Id3 deletion leads to dysregulation of the hematopoietic transcriptional network and multiple defects in erythropoietic development in adult mice |